Otsuka (OTCMKTS:OTSKF – Get Free Report) is projected to issue its results after the market closes on Friday, July 31st. Analysts expect Otsuka to post earnings of $1.01 per share and revenue of $3.9382 billion for the quarter.
Otsuka Price Performance
Shares of OTSKF opened at $66.50 on Thursday. Otsuka has a twelve month low of $54.26 and a twelve month high of $72.22. The company has a 50 day moving average of $65.28 and a 200-day moving average of $65.28.
About Otsuka
Otsuka Holdings Co, Ltd., trading on OTC markets as OTSKF, is a global healthcare company headquartered in Tokyo, Japan. Established in 1964 as a research-driven pharmaceutical firm, Otsuka has since evolved into a diversified holding company overseeing operations in pharmaceuticals, nutraceuticals and consumer products. The company operates through a network of subsidiaries, including Otsuka Pharmaceutical Co, Ltd., Otsuka America Pharmaceutical, Inc, and Otsuka Europe, each focusing on drug development, manufacturing and distribution.
In its pharmaceutical division, Otsuka is best known for discovering and commercializing treatments in areas such as psychiatry, oncology and nephrology.
Featured Stories
- Five stocks we like better than Otsuka
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
